Deal Type
Industry
Deal Status
Reason for Unit currently operating at 8% capacity and negative bottom line and cash flows
ØPlant was installed in March 2018 & commercial production license Dec 2018
ØRevenue operations commenced only in June – 2019
ØOnly 2 early years of Revenue curve & hence the above INR 40 million topline (8% of potential)
Ø
Other significant current considerations
ØPlant has been classified NPA for more than 1 year as Company unable to repay – Term + Covid loan of INR 110 Mln & further INR 34 Mln CC given the negative cash flows currently
Pharma Profile (1) pptx